The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

As per The Business Research Company’s Ambulatory IV infusion Pumps Global Market Report 2024, the ambulatory IV infusion pumps market is expected to show significant growth in the forecast period.

Steady Growth Projection

• From $0.81 billion in 2023 to $0.84 billion in 2024.
• Compound annual growth rate (CAGR) of 3.3%.

Factors Driving Historic Growth

• Rapid growth in the elderly population.
• Economic growth in emerging markets.
• Technological advancements.

Continued Expansion

• Estimated market size of $0.97 billion in 2028.
• CAGR of 3.7% in the forecast period.

View More On The Ambulatory IV infusion Pumps Market Report 2024 – https://www.thebusinessresearchcompany.com/report/ambulatory-iv-infusion-pumps-global-market-report

Factors Fueling Forecasted Growth

• Increasing prevalence of chronic diseases.
• Rising demand for improved infusion pumps.
• COVID-19 impact.
• Rise in healthcare expenditure.
• Increasing oncology cases in the geriatric population.

Trends to Watch

• Focus on smart ambulatory infusion pump devices and software.
• Development of new products.
• Deployment of technologies.
• Consideration of acquiring smaller drug delivery device companies.

Growing Prevalence of Chronic Diseases Fuels Demand for Ambulatory IV Infusion Pumps
Chronic illnesses such as cancer, diabetes, and chronic pain are on the rise globally, necessitating the use of ambulatory IV infusion pumps for treatment. These pumps deliver pharmaceutical drugs efficiently during the course of these diseases.

• Aging population and shifts in social behavior contribute to the rise in chronic diseases.
• Ambulatory IV infusion pumps administer regulated doses of drugs at home.
• WHO reports that chronic diseases account for 74% of all global deaths, highlighting the significance of these conditions.

Innovation in Ambulatory IV Infusion by Smart and Wireless Technology
Companies are increasingly focusing on developing smart infusion pumps, integrating wireless technology for enhanced usability and connectivity.

• Wireless technology facilitates data transfer and analysis, improving monitoring and reducing human error.
• Software platforms enable patient monitoring, enhancing healthcare delivery.

Fresenius Kabi Expands Infusion Capabilities With Ivenix Acquisition
In March 2022, Fresenius Kabi acquired Ivenix for $240 million, aiming to bolster innovation and expand their infusion therapy portfolio.

• The acquisition accelerates innovation and improves infusion capabilities.
• Ivenix, a US-based manufacturer of advanced infusion pumps, brings expertise and technology to Fresenius Kabi.

Market Segmentation
The ambulatory IV infusion pumps market is segmented based on therapy, application, and patient care setting.

1. By Therapy: Chemotherapy Infusion Pumps, Anti-Infective Infusion Pumps, Other Therapies
2. By Application: Chemotherapy or Oncology, Diabetes, Gastroenterology, Analgesia or Pain Management, Pediatrics or Neonatology, Hematology, Anti-Infective, Other Applications
3. By Patient Care Setting: Hospitals, Home Healthcare, Other End Users

Regional Insights

• North America emerged as the largest region in the ambulatory IV infusion pumps market in 2023, indicating significant market presence and potential growth opportunities in the region.

As the healthcare landscape continues to evolve, fueled by technological advancements and changing demographics, the ambulatory IV infusion pumps market stands poised for sustained growth, driven by the imperative need for effective chronic disease management and the quest for enhanced patient care delivery.

Request A Sample Of The Global Ambulatory IV infusion Pumps Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=3343&type=smp